This performance was made possible by the use of three major levers to confront the crisis: The first is the priority given to growth in volumes and market share through three initiatives: a market-by-market rebalancing of the product portfolio, increased promotion, and a readjustment of publicity. This prioritising meant a 5.2% increase in volumes sold in 2009, with the added benefit of protecting jobs within the group as well as at Danone’s industrial partners. The second lever is the staff’s adaptability, facilitated by efficient and committed operating structures in every country where Danone is present. The establishment of the Danone Ecosystem Fund is the third lever, supporting operations at the group’s direct and often local partners. Moreover, Danone continues to invest in Research & Development despite the economic climate - 206 million euros in 2009, or 1.4% of the company’s turnover.
Three centuries after the benefits of Evian mineral water were discovered, over a century after Blédine was first marketed, and nearly a century after the first Danone yoghurt was retailed in a pharmacy, health innovation remains more than ever a driver of the group’s business growth.
The baby nutrition and medical nutrition businesses, which Danone undertook in 2007 in buying up Numico, account respectively for 20% and 6% of the group’s 2009 turnover and increased significantly over 2008 (+7.9% and +11.4%). These two lines naturally round off the group’s brand portfolio and are perfectly aligned with its mission of bringing health through food to as many people as possible.
Today, Danone is the only food group to focus totally on health.
We are a multinational company operating in more than 120 countries worldwide with strong position in manufacturing and marketing quality food and beverage products. To cope with our rapid growth and international expansion, we are inviting well-trained high potential professionals to join our operation in Indonesia for the following positions:
